RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, announced that data on its defensin-mimetic antimicrobial compounds is being presented at the Malaria Keystone Conference: Drug Discovery for Protozoan Parasites in Breckenridge, Colorado. The poster presentation is being given by Dr. Doron Greenbaum of the University of Pennsylvania on Monday March 23 at 11:15 a.m.
